Biochemical and Functional Characterization by Site-Directed Mutagenesis of a Phospholipase A2 from Scorpio maurus Venom
Abstract
1. Introduction
2. Materials and Methods
2.1. Materials
2.2. Bacterial Strains, Plasmids, and Media
2.3. Site-Directed Mutagenesis Construction
2.4. Expression and Purification
2.5. Phospholipase A2 Assay
2.6. Hydrolysis of Phospholipid Monolayers
2.7. Hemolysis Assay
2.8. Temperature and pH Stability
2.9. Molecular Modeling
3. Results
3.1. Protein Expression and Purification
3.2. Apparent Kinetic Parameter Determination
3.3. Molecular Modeling Analysis
3.4. Stability Study
3.5. Correlation between Hemolytic Effect and Phospholipase Activity with Surface Pressure
4. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ivanušec, A.; Šribar, J.; Križaj, I. Secreted phospholipases A2—Not just enzymes: Revisited. Int. J. Biol. Sci. 2022, 18, 873. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Krayem, N.; Gargouri, Y. Scorpion venom phospholipases A2: A minireview. Toxicon Off. J. Int. Soc. Toxinol. 2020, 184, 48–54. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Suranse, V.; Jackson, T.N.; Sunagar, K. Contextual constraints: Dynamic evolution of snake venom phospholipase A2. Toxins 2022, 14, 420. [Google Scholar] [CrossRef] [Scilit]
- Soltan-Alinejad, P.; Alipour, H.; Meharabani, D.; Azizi, K. Therapeutic potential of bee and scorpion venom phospholipase A2 (PLA2): A narrative review. Iran. J. Med. Sci. 2022, 47, 300. [Google Scholar]
- Krayem, N.; Parsiegla, G.; Gaussier, H.; Louati, H.; Jallouli, R.; Mansuelle, P.; Carrière, F.; Gargouri, Y. Functional characterization and FTIR-based 3D modeling of full length and truncated forms of Scorpio maurus venom phospholipase A2. Biochim. Biophys. Acta (BBA)-Gen. Subj. 2018, 1862, 1247–1261. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hariprasad, G.; Kumar, M.; Srinivasan, A.; Kaur, P.; Singh, T.P.; Jithesh, O. Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: Targeting and reversible inhibition by native peptides. Int. J. Biol. Macromol. 2011, 48, 423–431. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Castro-Amorim, J.; Novo de Oliveira, A.; Da Silva, S.L.; Soares, A.M.; Mukherjee, A.K.; Ramos, M.J.; Fernandes, P.A. Catalytically Active Snake Venom PLA2 Enzymes: An Overview of Its Elusive Mechanisms of Reaction: Miniperspective. J. Med. Chem. 2023, 66, 5364–5376. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef] [PubMed]
- Pattus, F.; Slotboom, A.J.; de Haas, G.H. Regulation of the interaction of pancreatic phospholipase A2 with lipid-water interfaces by Ca2+ ions: A monolayer study. Biochemistry 1979, 18, 2698–2702. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Annand, R.R.; Kontoyianni, M.; Penzotti, J.E.; Dudler, T.; Lybrand, T.P.; Gelb, M.H. Active site of bee venom phospholipase A2: The role of histidine-34, aspartate-64 and tyrosine-87. Biochemistry 1996, 35, 4591–4601. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Scott, D.L.; Otwinowski, Z.; Gelb, M.H.; Sigler, P.B. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science 1990, 250, 1563–1566. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Doley, R.; King, G.F.; Mukherjee, A.K. Differential hydrolysis of erythrocyte and mitochondrial membrane phospholipids by two phospholipase A2 isoenzymes (NK-PLA2-I and NK-PLA2-II) from the venom of the Indian monocled cobra Naja kaouthia. Arch. Biochem. Biophys. 2004, 425, 1–13. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Devaux, P.F. Static and dynamic lipid asymmetry in cell membranes. Biochemistry 1991, 30, 1163–1173. [Google Scholar] [CrossRef] [Scilit] [PubMed]




| Mutant | Primers Used for PCR | cDNA Template | Amplified Region |
|---|---|---|---|
| E63D | PCR 1: Fw: primer 1 Rv: primer 2 | The cDNA encoding the rPLA2(−5) gene formed by 372 pb cloned into the pET21a(+) expression vector. | PCR1 product: 195 bp corresponding to residues 1 to 65 in the protein rPLA2(−5) sequence. |
| PCR 2: Fw: primer 3 Rv: primer 4 | PCR2 product: 177 pb encoding the rPLA2(−5) protein region from residues 66 to 124. | ||
| PCR 3: Fw: primer 1 Rv: primer 4 | Amplified products obtained from PCR1 and PCR2. | A cDNA encoding the mutant E63D constructed of 372 pb. | |
| Y122R | Fw: primer 1 Rv: primer 5 | The cDNA encoding to rPLA2(−5) gene formed by 372 pb cloned into the pET21a(+) expression vector. | A cDNA encoding the mutant Y122R constructed of 372 pb. |
| D63–R122 | Fw: primer 1 Rv: primer 5 | A cDNA encoding the mutant E63D constructed of 372 pb. | A cDNA encoding the mutant D63–R122 constructed of 372 pb. |
| Purification Steps | [Proteins] (mg/mL) a | Total Proteins (mg) | Activity (U/mL) b | Specific Activity (U/mg) | Proteins Recovery (%) |
|---|---|---|---|---|---|
| Inclusion bodies solubilization | 0.42 ± 0.12 | 8.5 ± 0.21 | - | - | - |
| E63D | |||||
| Refolding | 0.32 ± 0.13 | 6.4 ± 0.19 | 3 ± 1 | 9.3 ± 2 | 75.29 ± 5 |
| Affinity chromatography | 0.60 ± 0.21 | 1.2 ± 0.11 | 50 ± 4 | 82.5 ± 4 | 18.75 ± 4 |
| Y122R | |||||
| Refolding | 0.30 ± 0.17 | 6 ± 0.18 | 14 ± 2 | 35 ± 3 | 70.42 ± 8 |
| Affinity chromatography | 0.65 ± 0.18 | 1.5 ± 0.16 | 70 ± 5 | 107 ± 6 | 21.66 ± 3 |
| D63–R122 | |||||
| Refolding | 0.29 ± 0.15 | 5.8 ± 0.15 | 0 | 0 | 68.23 ± 10 |
| Affinity chromatography | 0.71 ± 0.2 | 1.48 ± 0.2 | 0 | 0 | 24.13 ± 4 |
| rPLA2(−5) | |||||
| Refolding | 1.25 ± 0.5 | 6 ± 2 | 375 ± 15 | 300 ± 18 | 70.58 ± 3 |
| Affinity chromatography | 0.5 ± 0.25 | 3 ± 0.5 | 750 ± 20 | 1500 ± 27 | 50 ± 4 |
| Enzymes | Vmax (µmol/min/mg) | Km (mM) | kcat (s−1) | Kcat/Km (s−1·mM−1) | Reference |
|---|---|---|---|---|---|
| rPLA2(−5) | 1500 ± 7 | 4.23 ± 0.35 | 354 ± 2 | 83.86 ± 8 | [5] |
| E63D | 9.3 ± 2 | 8.33 ± 2 | 32.7 ± 1.5 | 3.92 ± 2.3 | Present study |
| Y122R | 107 ± 6 | 1.8 ± 0.7 | 25.4 ± 3 | 14.11 ± 2 | |
| D63–R122 | 0 | 0 | 0 | - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Krayem, N.; Alonazi, M.; Khemakhem, B.; Horchani, H.; Cherif, S.; Karray, A.; Ben Bacha, A. Biochemical and Functional Characterization by Site-Directed Mutagenesis of a Phospholipase A2 from Scorpio maurus Venom. Processes 2023, 11, 3364. https://doi.org/10.3390/pr11123364
Krayem N, Alonazi M, Khemakhem B, Horchani H, Cherif S, Karray A, Ben Bacha A. Biochemical and Functional Characterization by Site-Directed Mutagenesis of a Phospholipase A2 from Scorpio maurus Venom. Processes. 2023; 11(12):3364. https://doi.org/10.3390/pr11123364
Chicago/Turabian StyleKrayem, Najeh, Mona Alonazi, Bassem Khemakhem, Habib Horchani, Slim Cherif, Aida Karray, and Abir Ben Bacha. 2023. "Biochemical and Functional Characterization by Site-Directed Mutagenesis of a Phospholipase A2 from Scorpio maurus Venom" Processes 11, no. 12: 3364. https://doi.org/10.3390/pr11123364
APA StyleKrayem, N., Alonazi, M., Khemakhem, B., Horchani, H., Cherif, S., Karray, A., & Ben Bacha, A. (2023). Biochemical and Functional Characterization by Site-Directed Mutagenesis of a Phospholipase A2 from Scorpio maurus Venom. Processes, 11(12), 3364. https://doi.org/10.3390/pr11123364

